Preparation and evaluation of silymarin β-cyclodextrin molecular inclusion complexes

Journal of Young Pharmacists

Volumn 3, Issue 3, 2011, Pages 205-210

  Ghosh, A ^a   Biswas, S ^a   Ghosh, T ^a  

^a HIMALAYAN PHARMACY INSTITUTE   (India)

Author keywords

Bioavailability; Inclusion complexes; Silymarin; Cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; SILYMARIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; EVAPORATION; LIVER PROTECTION; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLVENT EFFECT; SUSTAINED RELEASE FORMULATION; X RAY DIFFRACTION;

EID: 80051889515     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.83759     Document Type: Article

References (18)

1. Luper SA. Review of plants used in the treatment of liver disease, Part 1. Altern Med Rev 1998;3:410-21.
2. Pradhan SC, Girish C. Hepatoprotective herbal drug, Silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 2006;124:491-504. (Pubitemid 46157708)
3. Reynolds JE. Martindale the Extra Pharmacopoeia. London: Pharmaceutical Press; 2002.
4. Pepping J. Milk thistle: Silybum marianum. Am J Health Sys Pharma 1999;56:1195-7.
5. Saller R, Meier R, Brignoli R. The use of Silymarin in the treatment of liver diseases. Drugs 2001;61:2035-63. (Pubitemid 33135182)
6. Pinnamaneni S, Das N, Das SK. Formulation approaches for orally administered poorly soluble drugs. Pharmazie 2002;57:291-300. (Pubitemid 34517296)
7. Deshmukh SS, Potnis VV, Shelar DB, Mahaparale PR. Studies on inclusion complexes of ziprasone hydrochloride with β cyclodextrin and hydroxypropyl cyclodextrin. Indian Drugs 2007;44:677-82.
8. Patil JS, Pandya NR, Marapur SC, Shiralashetti SS. Influence of method of preparation on physiochemical properties and in vitro drug release profile of nimodipine-cyclodextrin inclusion complexes: A comparative study. Int J Pharmacy Pharmaceutical Sci 2010;2:71-81.
9. Loftsson T, Brewster ME, Masson M. Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv 2004;2:1-15.
10. Nagarsenkar MS, Meshram R, Ramprakash G. Solid dispersion of hydroxypropyl a cyclodextrin and Ketorolac: Enhancement of in vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenecity in rats. J Pharm Pharmacol 2000;52:949-56.
11. Reddy MN, Chowdary KP, Diwan PV. β-Cyclodextrin complexes of celecoxib: Molecular modeling, characterization and dissolution studies. AAPS Pharm Sci 2004;6:E7.
12. Loftsson T, Brewster ME. Pharmaceutical application of cyclodextrin in drug solubilisation and stabilization. J Pharm Sci 1996;85:1017-25. (Pubitemid 26338912)
13. Kamal D, Ramana MD, Himaja M, Agarwal A, Garg V. Investigation of enhancement of solubility of norfloxacin beta cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv 2007;4:21-5. (Pubitemid 46066411)
14. Attma AA, Ndibe ON, Nnamani PO. Studies on diclofenac-β-Cyclodextrin inclusion complexes. J Pharm Res 2004;3:47-9.
15. Soniwala MM, Patel PR, Ansuri MS, Parikh RK, Goel MC. Various approaches in dissolution enhancement of Rofecoxib. Indian J Pharm Sci 2005;67:61-3.
16. Aries MJ, Moyano JR, Munoz P, Justo A. Study of Omeprazole-g-cyclodextrin complexation in the solid state. Drug Dev Ind Pharm 2000;26:253-9. (Pubitemid 30164740)
17. Becket G, Schep LJ, Tan MY. Improvement of the in vitro dissolution of praziquantel by complexation with α-, β-, and γ-cyclodextrin. Int J Pharm 1999;179:65-71. (Pubitemid 29115061)
18. Bekers O, Uijtendaal EV, Beijnen JH, Bult A, Underberg WJ. Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 1991;17:1503-49.